Matthews China Innovators Active ETF (MCHS)

On our desk, MCHS is tracking some very compelling momentum. Looking at the YTD numbers pushing past 45% and a strong 1-year print north of 60%, the active strategy targeting China's innovative sectors is capturing real upside. However, we have to keep a close eye on the order book. With AUM sitting around $22 million, liquidity can be thin on certain days, meaning wider spreads if you're trying to scale in or out of a position quickly. It's a high-alpha play, but position sizing needs to reflect the boutique asset scale.

From a risk perspective, the structural setup of MCHS demands caution. Even though the recent performance metrics look fantastic—especially the 6-month rebound—the net expense ratio of 0.89% eats into returns over time. Furthermore, shifting mandates or renaming the fund from the China Discovery Active ETF to the China Innovators Active ETF shows a clear pivot toward capturing hot themes, but investors must remember they are taking on concentrated regulatory and market risks tied specifically to Chinese equities and domestic consumer demand cycles.

When analyzing the human capital pillar for MCHS, the recent appointment of Tiffany Hsiao as Portfolio Manager across the Matthews China Small Companies and China Innovators strategies provides a clear continuity of specialized oversight. If you are evaluating the fund's process pillar, you need to understand their mandate: they are required to invest at least 80% of net assets in companies considered innovators in products, services, or technology within China and Hong Kong. Analysts interviewing or pitching this fund should focus heavily on how the active management team navigates capital efficiency versus macro policy shifts in the region.